Portage Biotech: Adport-601 Trial Is Paused for Further Patient Accrual Pending Additional Financial Resources
Portage Biotech: Adport-601試驗因等待額外資金而暫停進一步招募患者
Portage Biotech: Adport-601 Trial Is Paused for Further Patient Accrual Pending Additional Financial Resources
Portage Biotech: Adport-601試驗因等待額外資金而暫停進一步招募患者
譯文內容由第三人軟體翻譯。
使用瀏覽器的分享功能,分享給你的好友吧